藥物研發服務市場規模、佔有率、成長分析（按流程、按類型、按治療領域、按藥物類型、按技術、按最終用戶、按地區）—產業預測 2025-2032

2023 年全球藥物研發服務市場價值為 43 億美元，預計將從 2024 年的 46.4 億美元成長到 2032 年的 86 億美元，預測期間（2025-2032 年）的複合年成長率為 8.0%。

由於各種未滿足的醫療需求，包括神經退化性疾病、癌症、罕見遺傳疾病和心血管疾病，對創新藥物的需求仍然很高。隨著新疾病的出現，開發新藥的努力愈加活躍，藥物發現服務市場預計將顯著成長。這個複雜的過程需要毒理學、藥物化學和藥理學等領域專家的合作，因此研究機構和製藥公司通常會將這些服務外包，以提高成本和時間效率。大型製藥企業正在大力投資研發，以提高效率並開發專注於罕見疾病和孤兒藥的新收益來源。然而，嚴格的法規和熟練專業人員短缺等挑戰可能會影響市場的擴張。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析

藥物研發服務市場規模（按流程和複合年成長率） (2025-2032)

• 市場概覽
• 目標選擇
• 目標檢驗
• 命中至線索流程
• 候選人檢驗
• 其他

藥物研發服務市場規模（按類型及複合年成長率）（2025-2032）

• 市場概覽
• 藥物化學
• 生物服務
• 藥物代謝
• 醫藥服務
• 藥物動力學

藥物研發服務市場規模（依治療領域及複合年成長率）（2025-2032）

• 市場概覽
• 腫瘤學
• 神經病學
• 心血管疾病
• 呼吸系統疾病
• 糖尿病
• 其他

藥物研發服務市場規模（依藥物類型及複合年成長率）（2025-2032）

• 市場概覽
• 小分子
• 生物製藥

藥物研發服務市場規模（依技術及複合年成長率） (2025-2032)

• 市場概覽
• 高通量篩檢
• 生物晶片
• 藥物基因學
• 奈米科技
• 光譜學

藥物研發服務市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院和診所
• 製藥公司
• 生技公司
• 研究機構

藥物研發服務市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Charles River Laboratories（USA）
• WuXi AppTec（China）
• Thermo Fisher Scientific Inc.（USA）
• Evotec SE（Germany）
• Pharmaron（China）
• Labcorp（USA）
• Syngene International Limited（India）
• Eurofins Scientific（Luxembourg）
• Jubilant Biosys Limited（India）
• Curia Global, Inc.（USA）
• GenScript（USA）
• Frontage Holdings Corporation（USA）
• Piramal Enterprises Ltd.（India）
• Aragen Life Sciences Ltd.（India）
• Sygnature Discovery（UK）
• Selvita SA（Poland）
• Viva Biotech（China）
• TCG Lifesciences Pvt. Ltd.（India）
• Medicilon（China）
• Sai Life Sciences Limited（India）

結論和建議

Global Drug Discovery Services Market size was valued at USD 4.3 billion in 2023 and is poised to grow from USD 4.64 billion in 2024 to USD 8.6 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The demand for innovative drugs remains significant, driven by various unmet medical needs across neurodegenerative diseases, cancers, rare genetic disorders, and cardiovascular issues. As new diseases emerge, the drug discovery services market is poised for considerable growth due to heightened efforts in novel drug development. This complex process necessitates collaboration among experts in fields such as toxicology, medicinal chemistry, and pharmacology, often leading research institutions and pharmaceutical companies to outsource these services for cost and time efficiencies. Major pharmaceutical firms are investing heavily in R&D to enhance efficiency and tap into fresh revenue streams focused on rare diseases and orphan drug initiatives. However, challenges such as stringent regulations and a shortage of skilled professionals may affect market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Services Market Segments Analysis

Global Drug Discovery Services Market is segmented by Process, Type, Therapeutic Area, Drug Type, Technology, End User and region. Based on Process, the market is segmented into Target Selection, Target Validation, Hit-To-Lead Identification, Candidate Validation and Others. Based on Type, the market is segmented into Medicinal Chemistry, Biology Services, Drug Metabolism, Pharmaceutical Services and Pharmacokinetics. Based on Therapeutic Area, the market is segmented into Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes and Others. Based on Drug Type, the market is segmented into Small Molecules and Biologics. Based on Technology, the market is segmented into High Throughput Screening, Biochips, Pharmacogenetics, Nanotechnology and Spectroscopy. Based on End User, the market is segmented into Hospital & Clinics, Pharmaceutical Companies, Biotechnology Companies and Research Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Discovery Services Market

The global drug discovery services market is significantly driven by the rising prevalence of chronic diseases such as diabetes, dementia, and cardiovascular conditions, which collectively account for over 40 million deaths annually, representing seven out of ten fatalities worldwide. As the incidence of these chronic illnesses continues to escalate, it is anticipated that the demand for drug discovery services will expand throughout the forecast period. This surge in chronic diseases not only highlights the urgent need for effective therapeutic interventions but also presents lucrative economic opportunities for companies specializing in drug discovery, as the market increasingly seeks innovative medication solutions.

Restraints in the Global Drug Discovery Services Market

One of the key constraints affecting the Global Drug Discovery Services market is the stringent focus of regulatory agencies on ensuring the safety and efficacy of drugs before approval. Although these thorough processes are essential for maintaining confidence in medicine quality, they significantly escalate the costs associated with drug development, ultimately resulting in higher prices for the end products. This is particularly crucial in price-sensitive emerging economies, where the elevated costs can substantially hinder the adoption and accessibility of new medicines, thereby impacting overall market growth and limiting patient access to vital treatments.

Market Trends of the Global Drug Discovery Services Market

The Global Drug Discovery Services market is experiencing significant growth, driven by an escalating demand for novel therapies that address chronic diseases and improve patient outcomes. As global healthcare systems expand and evolve, pharmaceutical companies are increasingly investing in clinical trials to seek innovative solutions. This trend is further bolstered by advancements in technologies such as AI and genomics, which streamline the drug discovery process. Consequently, the market is witnessing a surge in collaboration between biopharmaceutical firms and contract research organizations (CROs), facilitating the rapid progression of drug development and increasing the overall market value.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis

Global Drug Discovery Services Market Size by Process & CAGR (2025-2032)

• Market Overview
• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Candidate Validation
• Others

Global Drug Discovery Services Market Size by Type & CAGR (2025-2032)

• Market Overview
• Medicinal Chemistry
• Biology Services
• Drug Metabolism
• Pharmaceutical Services
• Pharmacokinetics

Global Drug Discovery Services Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Oncology
• Neurology
• Cardiovascular Disease
• Respiratory Disease
• Diabetes
• Others

Global Drug Discovery Services Market Size by Drug Type & CAGR (2025-2032)

• Market Overview
• Small Molecules
• Biologics

Global Drug Discovery Services Market Size by Technology & CAGR (2025-2032)

• Market Overview
• High Throughput Screening
• Biochips
• Pharmacogenetics
• Nanotechnology
• Spectroscopy

Global Drug Discovery Services Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital & Clinics
• Pharmaceutical Companies
• Biotechnology Companies
• Research Institute

Global Drug Discovery Services Market Size & CAGR (2025-2032)

• North America (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
  • US
  • Canada
• Europe (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evotec SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaron (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene International Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Biosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curia Global, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Holdings Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Enterprises Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aragen Life Sciences Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sygnature Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Selvita SA (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viva Biotech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TCG Lifesciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicilon (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sai Life Sciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations